Mylan, now a part of Viatris, offers a broad portfolio of generic and specialty pharmaceutical products. Through the combination with Upjohn, a legacy division of Pfizer, the company has evolved to empower people worldwide to live healthier at every stage of life. Mylan is committed to delivering high-quality medicines that meet the diverse healthcare needs of patients globally.

Services include:
– Active Pharmaceutical Ingredients (APIs)
– Generic pharmaceuticals
– Specialty pharmaceuticals
– Biologics
– Over-the-counter (OTC) products
– Strategic partnerships and collaborations

Mylan plays a significant role in the pharmaceutical industry by ensuring access to essential medications and fostering innovation. For more information, visit mylan.com.